These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12665269

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG, Millar AB, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [Abstract] [Full Text] [Related]

  • 23. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 24. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma.
    Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt WR.
    J Allergy Clin Immunol; 1999 May 29; 103(5 Pt 1):796-803. PubMed ID: 10329812
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
    Stoloff SW, Srebro SH, Edwards LD, Johnson MC, Rickard KA.
    MedGenMed; 2001 Jun 08; 3(3):2. PubMed ID: 11549975
    [Abstract] [Full Text] [Related]

  • 27. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.
    Respir Med; 2009 Jan 08; 103(1):41-9. PubMed ID: 18977646
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma.
    Grzelewska-Rzymowska I, Kroczynska-Bednarek J, Zarkovic J.
    Respir Med; 2003 Feb 08; 97 Suppl B():S21-6. PubMed ID: 12593524
    [Abstract] [Full Text] [Related]

  • 31. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug 08; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP, Lundback B, Yigla M, Sykes AP.
    Respir Med; 2000 Jun 08; 94 Suppl B():S35-41. PubMed ID: 10919684
    [Abstract] [Full Text] [Related]

  • 34. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U, Price D, Howes T, Sussman G.
    J Asthma; 2008 Apr 08; 45(3):215-20. PubMed ID: 18415829
    [Abstract] [Full Text] [Related]

  • 35. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
    J Allergy Clin Immunol; 1998 Jul 08; 102(1):32-8. PubMed ID: 9679845
    [Abstract] [Full Text] [Related]

  • 36. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
    Ann Allergy Asthma Immunol; 1997 Apr 08; 78(4):356-62. PubMed ID: 9109702
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M, Wettenger R, Gans SJ.
    Respir Med; 2001 Mar 08; 95(3):212-20. PubMed ID: 11266239
    [Abstract] [Full Text] [Related]

  • 38. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate.
    Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T, Koshishi T, Oka K, Homma M.
    J Asthma; 2003 Mar 08; 40(5):515-22. PubMed ID: 14529101
    [Abstract] [Full Text] [Related]

  • 39. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
    Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.
    J Asthma; 2001 May 08; 38(3):229-37. PubMed ID: 11392363
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
    Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
    Ann Allergy Asthma Immunol; 1996 Aug 08; 77(2):112-8. PubMed ID: 8760776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.